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Abstract
Abnormal phosphorylation and toxicity of a microtubule-associated protein tau are involved in the pathogenesis of
Alzheimer’s disease (AD); however, what pathological conditions trigger tau abnormality in AD is not fully understood. A
reduction in the number of mitochondria in the axon has been implicated in AD. In this study, we investigated whether and
how loss of axonal mitochondria promotes tau phosphorylation and toxicity in vivo. Using transgenic Drosophila expressing
human tau, we found that RNAi–mediated knockdown of milton or Miro, an adaptor protein essential for axonal transport of
mitochondria, enhanced human tau-induced neurodegeneration. Tau phosphorylation at an AD–related site Ser262
increased with knockdown of milton or Miro; and partitioning defective-1 (PAR-1), the Drosophila homolog of mammalian
microtubule affinity-regulating kinase, mediated this increase of tau phosphorylation. Tau phosphorylation at Ser262 has
been reported to promote tau detachment from microtubules, and we found that the levels of microtubule-unbound free
tau increased by milton knockdown. Blocking tau phosphorylation at Ser262 site by PAR-1 knockdown or by mutating the
Ser262 site to unphosphorylatable alanine suppressed the enhancement of tau-induced neurodegeneration caused by
milton knockdown. Furthermore, knockdown of milton or Miro increased the levels of active PAR-1. These results suggest
that an increase in tau phosphorylation at Ser262 through PAR-1 contributes to tau-mediated neurodegeneration under a
pathological condition in which axonal mitochondria is depleted. Intriguingly, we found that knockdown of milton or Miro
alone caused late-onset neurodegeneration in the fly brain, and this neurodegeneration could be suppressed by
knockdown of Drosophila tau or PAR-1. Our results suggest that loss of axonal mitochondria may play an important role in
tau phosphorylation and toxicity in the pathogenesis of AD.
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Introduction
Mitochondria are principal mediators of local ATP supply and
Ca2+ buffering. In neuronal axons, these requirements need to be
addressed locally, and the proper distribution of mitochondria is
essential for neuronal functions and survival [1]. Defects in
mitochondrial distribution have been observed in the brains of
patients suffering from several neurodegenerative diseases including
Alzheimer’s disease (AD) [2]. Recent studies have shown that the
localization of mitochondria to the axon is reduced in neurons in the
AD brain, as well as in cellular and animal models of AD [3–14].
The reduction inmitochondria in the axonmay be due to alterations
in mitochondrial fission/fusion [3,5,6] and/or due to defects in the
axonal transport of mitochondria [4,6,8,10–12]. However, how it
contributes to the pathogenesis of AD remains elusive.
Tau is a microtubule-associated protein that is expressed in
neurons and localizes predominantly in the axons, where it
regulates microtubule dynamics. Tau is phosphorylated at a
number of sites, and a fine-tuned balance between phosphoryla-
tion and dephosphorylation of tau is critical for its physiological
functions, such as microtubule stabilization, in the axons [15].
Hyperphosphorylated tau is found in neurofibrillary tangles, the
intracellular protein inclusions that are associated with a range of
neurodegenerative diseases including AD [15]. In AD brains, tau
phosphorylation is abnormally increased at several specific sites,
and these changes are associated with tau toxicity [15,16].
However, the effects of loss of axonal mitochondria on abnormal
phosphorylation and toxicity of tau has not been fully elucidated.
Mitochondrial transport is regulated by a series of molecular
adaptors that mediate the attachment of mitochondria to
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molecular motors [17]. In Drosophila, mitochondrial transport is
facilitated by milton and Miro, which regulate mitochondrial
attachment to microtubules via kinesin heavy chain [18,19]. In
mammals, two isoforms of milton (OIP106 and GRIF1) and Miro
(Miro1 and Miro2) have been identified and are proposed to act in
a similar manner [20]. In Drosophila, in the absence of milton or
Miro, synaptic terminals and axons lack mitochondria, although
mitochondria are numerous in the neuronal cell body [18,21].
In this study, using Drosophila as a model system, we investigated
the effects of knockdown of milton or Miro, an adaptor protein
essential for axonal transport of mitochondria, on tau phosphor-
ylation and toxicity. We demonstrate that loss of axonal
mitochondria caused by milton knockdown increases tau phos-
phorylation at Ser262 through PAR-1, promotes detachment of
tau from microtubules, and enhances tau-mediated neurodegen-
eration.
Results
Knockdown of milton or Miro significantly enhances
human tau-mediated neurodegeneration
To test whether loss of axonal mitochondria enhances human
tau toxicity in vivo, we used transgenic Drosophila expressing human
tau [22]. Wild-type human 0N4R tau, which has four tubulin-
binding domains (R) and no N-terminal insert (N), was expressed
in fly eyes using the GAL4/UAS system [23] with the pan-retinal
gmr-GAL4 driver. Expression of human tau causes age-dependent
and progressive neurodegeneration in the lamina, the first synaptic
neuropil of the optic lobe containing photoreceptor axons:
degeneration in the lamina is undetectable or very mild in flies
at 3-day-old, while it is prominent at 10-day-old (Figure S1A and
S1B; S1D, quantification).
It has been reported that overexpression of tau alone can reduce
anterograde transport of a variety of kinesin cargos, including
mitochondria [4,9,11,12,24]. We examined whether tau expres-
sion alone causes the loss of mitochondria at the synaptic terminals
of young tau flies by electron microscopy. Mitochondria were
observed in the synaptic terminals of photoreceptor neurons
expressing tau at 3-day-old (Figure S2), suggesting that, under our
experimental conditions, severe defects in microtubule-dependent
transport are not occurred in the young flies expressing human
tau.
Milton is a component of an adaptor complex that links
mitochondria to kinesin heavy chain and is essential for axonal
transport of mitochondria (Figure 1A) [19]. Previously, we have
shown that milton RNAi expression effectively reduces milton
protein levels, reduces the axonal distribution of mitochondria and
increases the mitochondrial localization to the cell body in the fly
brain [7]. We confirmed that expression of milton RNAi in fly eyes
caused loss of mitochondria in the synaptic terminals of the
photoreceptor neurons by electron microscopy analysis. Mito-
chondria were seldom observed in the synaptic terminals of
photoreceptor neurons expressing milton RNAi, while mitochon-
dria were abundant in the synaptic terminals of control flies
(compare Figure 1B and 1C). In addition, the presynaptic
terminals contained vesicles with a wider range of sizes in the
milton knockdown flies than in controls (Figure S3), as previously
observed in milton mutant flies [25].
To investigate tau toxicity under the condition in which
mitochondria are chronically depleted from the axon, we co-
expressed milton RNAi with human tau. We confirmed that
milton knockdown caused loss of axonal mitochondria in the
neurons expressing tau by electron microscopy (Figure S4). Co-
expression of tau with milton RNAi (milton RNAiGD) dramatically
enhanced neurodegeneration in the lamina at 3-day-old compared
to fly eyes expressing tau alone (Figure 1E and 1F; 1M,
quantification). In 3-day-old flies, knockdown of milton alone
did not cause neurodegeneration (Figure 1H) [21]. To limit the
possibility of off-target effects of RNAi, another independent
transgenic fly line carrying a milton RNAi that targets a different
region of milton (milton RNAiTRiP) was used. Expression of this
RNAi in neurons reduced milton mRNA levels in the fly brain
(Figure S5A) as well as the axonal distribution of mitochondria
(Figure S5B). The enhancement of tau-induced neurodegeneration
was also observed with milton RNAiTRiP (Figure 1G; 1M,
quantification).
We also tested the effect of knockdown of Miro, which is
another critical component of the adaptor complex that controls
mitochondrial trafficking in the axons [18,19] (Figure 1A), on tau-
mediated neurodegeneration. Expression of Miro RNAi (Miro
RNAiKK) [26] reduced the axonal distribution of mitochondria in
the fly brain (Figure S6) and significantly enhanced tau-induced
neurodegeneration (Figure 1I; 1M, quantification). To limit the
possibility of off-target effects of RNAi, we generated another
independent transgenic fly line carrying Miro RNAi (Miro
RNAiiai) that targets a different region of Miro. Expression of
Miro RNAiiai reduced Miro mRNA levels (Figure S7) and
significantly enhanced tau-induced neurodegeneration (Figure 1J;
1M, quantification). Similar to a previous report [21], knockdown
of Miro alone did not cause neurodegeneration in 3-day-old flies
(Figure 1K).
The enhancement of tau-induced neurodegeneration by milton
RNAi or Miro RNAi is not due to non-specific effects of RNAi
overexpression, since the expression of an RNAi against firefly
luciferase (Figure 1L), as well as the expression of many other
RNAis (Figure S8), did not enhance tau-induced neurodegener-
ation.
Expression of human tau in Drosophila eyes reduces the external
eye size (Figure S9B), which is due to apoptosis during the larval
stage [27]. Genetic screens assessing changes in this phenotype
have identified a number of modifiers of tau toxicity [28–30].
Author Summary
Abnormal phosphorylation and toxicity of a microtubule-
associated protein tau are involved in the pathogenesis of
Alzheimer’s disease (AD). Tau is phosphorylated at multiple
sites, and phosphorylation of tau regulates its microtubule
binding and physiological functions such as regulation of
microtubule stability. Abnormal phosphorylation of tau
occurs in the AD brains and is thought to cause tau
toxicity; however, what pathological conditions trigger
abnormal phosphorylation and toxicity of tau in AD is not
fully understood. Since a reduction in the number of
mitochondria in the axon has been observed in the AD
brains, we investigated whether and how loss of axonal
mitochondria promotes tau phosphorylation and toxicity.
Using transgenic flies expressing human tau, we found
that knockdown of milton or Miro, an adaptor protein
essential for axonal transport of mitochondria, enhanced
human tau-induced neurodegeneration. This study dem-
onstrates that loss of axonal mitochondria caused by
milton knockdown increases tau phosphorylation at an
AD–related site through partitioning defective-1 (PAR-1),
promotes detachment of tau from microtubules, and
enhances tau-mediated neurodegeneration. Our results
suggest that loss of axonal mitochondria may play an
important role in tau phosphorylation and toxicity in the
pathogenesis of AD.
Loss of Axonal Mitochondria Promotes Tau Toxicity
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Figure 1. RNAi–mediated knockdown of milton or Miro enhances human tau-induced neurodegeneration. (A) The mitochondrial
transport machinery. (B–C) Transmission electron micrographs of presynaptic terminals in the lamina of flies expressing milton RNAi with the gmr-
GAL4 driver (B) and control flies bearing the gmr-GAL4 driver only (C). Presynaptic terminals in B and C are colored green to accentuate the structures.
Arrows in C indicate mitochondria in synaptic terminals. Note that synaptic terminals in milton knockdown flies (B) lack mitochondria, while the
synaptic terminals of control flies (C) contain mitochondria. Flies are 3 days-after-eclosion (day-old). (D–M) The lamina of control flies bearing the
driver only (D), flies expressing tau alone (E), co-expressing tau and milton RNAiGD (F), co-expressing tau and milton RNAiTRiP (G), expressing milton
RNAiGD alone (H), co-expressing tau and Miro RNAiKK (I), co-expressing tau and Miro RNAiiai (J), expressing Miro RNAiiai alone (K), or co-expressing tau
and luciferase RNAi (L). In E and L, neurodegeneration is indicated by arrows. (M) Quantification of neurodegeneration, mean 6 SEM, n = 10–33.
*, p,0.05, Student’s t-test. Flies were 3 days-after-eclosion (day-old).
doi:10.1371/journal.pgen.1002918.g001
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However, neither milton nor Miro was identified in the previous
screens [28–30]. We found that knockdown of either milton or
Miro did not enhance the tau-induced reduction in external eye
size (Figure S9C and S9D). These results indicate that the modifier
screen using tau-induced lamina degeneration as a read-out
phenotype yields new genes involved in tau-induced neurodegen-
eration.
Taken together, these results demonstrate that the knockdown of
milton or Miro enhances human tau-mediated neurodegeneration.
Milton knockdown enhances tau-induced axon
degeneration without neurofibrillary tangle formation
Neurodegeneration in the lamina in flies expressing tau alone
(Figure 2A) or expressing tau and milton RNAi (Figure 2B, 2E, 2F
and 2G) at 3-day-old was examined at the ultrastructural level.
Axon pathology, including the formation of vacuoles in the axons
(asterisks in Figure 2A, 2B and 2E) and swollen axons (arrows in
Figure 2E), were observed. In the presynaptic terminals, vacuoles
(Figure 2F, asterisks) and the accumulation of autophagic bodies
and multivesicular bodies (Figure 2F and 2G, arrows) were
observed. These pathological changes were more severe and
prominent in the lamina of flies expressing tau and milton RNAi
than in flies expressing tau alone. Neurofibrillary tangles were not
detected in flies expressing human tau and milton RNAi,
indicating that milton knockdown enhances the tau-induced
axonopathy without the formation of large tau aggregates. Axonal
or presynaptic degeneration was not observed in the control flies
(Figure 2C and 2H) or in flies with milton knockdown alone at 3-
day-old (Figure 2D and 2I).
Milton knockdown increases tau phosphorylation levels
at AD–related Ser262
A group of Ser/Thr phosphorylation sites in tau is abnormally
phosphorylated in the AD brain [31]. Using well-characterized
phospho-tau-specific antibodies, we examined whether milton
knockdown affects tau phosphorylation at AD-related sites by
Western blotting. The level of tau phosphorylated at Ser262 was
significantly increased by milton knockdown (Figure 3A). Knock-
down of Miro also increased the levels of tau phosphorylated at
Ser262 (Figure 3B). In contrast, tau phosphorylation at the AT8
epitope (phospho-Ser202) or the AT180 epitope (phospho-Thr231)
was not significantly altered by milton knockdown (Figure 3A). The
levels of total tau were not significantly changed (Figure 3A),
indicating that milton knockdown does not cause tau accumulation.
Tau phosphorylation at Ser262 has been reported to reduce tau
binding to microtubules [32,33]. We tested whether milton
knockdown alters the binding of tau to microtubules by using
microtubule binding assay. Microtubules and microtubule-bound
proteins were recovered as the pellet by centrifugation from brains
of flies expressing human tau alone or co-expressing human tau
and milton RNAi. The pellet (microtubule-bound fraction) and
supernatant (microtubule-free fraction) were separated by SDS-
PAGE, and tau levels in these fractions were analyzed by Western
blotting. Milton knockdown caused a significant reduction in the
amount of tau in the pellet and an increase in tau in the
supernatant (Figure 3C). This result indicates that milton
knockdown reduces tau binding to microtubules and increases
the levels of microtubule-unbound, free tau in the fly brain.
PAR-1 mediates the increase in tau phosphorylation at
Ser262 caused by milton knockdown
Drosophila partitioning defective-1 (PAR-1) and the mammalian
homolog of PAR-1, microtubule affinity-regulating kinase
(MARK), are reported to phosphorylate tau at Ser262 in vivo
[34,35]. RNAi-mediated knockdown of PAR-1 in fly eyes caused a
significant reduction in tau phosphorylation at Ser262, suggesting
that PAR-1 is the major Ser262 kinase in the fly eye (Figure 4A)
[35]. We examined whether blocking PAR-1 activity suppresses
the increase in tau phosphorylation at Ser262 caused by milton
knockdown. In the PAR-1 knockdown background, milton
knockdown did not increase tau phosphorylation levels at
Ser262 (Figure 4B), indicating that PAR-1 mediates the increase
in tau phosphorylation at Ser262 caused by milton knockdown.
PAR-1 and tau phosphorylation site Ser262 are critical for
the enhancement of tau-induced axon degeneration
caused by milton knockdown
We investigated the role of tau phosphorylation at Ser262 in the
enhancement of tau-induced axon degeneration caused by milton
knockdown. We first examined whether PAR-1 knockdown
enhances or suppresses tau-induced axon degeneration in the
milton knockdown background. RNAi-mediated knockdown of
PAR-1 significantly suppressed neurodegeneration in the lamina
of flies expressing human tau and milton RNAi (Figure 5A and 5B;
5D, quantification). This effect is not due to titration of the
effectiveness of RNAi, since the expression of an RNAi against
firefly luciferase did not significantly suppress tau-induced
neurodegeneration in the milton knockdown background
(Figure 5A and 5C; 5D, quantification).
Next, to determine whether the Ser262 site is required for the
knockdown of milton to enhance tau-induced axon degeneration,
transgenic flies carrying human tau with the S262A mutation
(S262A tau) expressed at the levels similar to the expression of
wild-type tau ([36] and Figure 5E) were used. It has been reported
that introduction of the S262A mutation dramatically rescues tau-
induced reduction in external eye size [35,36], which is due to
apoptosis during the larval stage [27]. Interestingly, we found that
expression of S262A tau caused age-dependent neurodegeneration
in the lamina similar to that caused by wild type tau: in the flies
expressing S262A tau, degeneration in the lamina was undetect-
able or very mild in flies at 3-day-old, while it was prominent at
10-day-old (Figure S10). Using S262A tau flies, we found that the
introduction of the S262A mutation suppressed the enhancement
of tau-induced axon degeneration caused by milton knockdown
(Figure 5F and 5G; 5H, quantification). Taken together, these
results suggest that tau phosphorylation at Ser262 and PAR-1 play
a critical role in the enhancement of tau-induced neurodegener-
ation caused by milton knockdown.
Knockdown of milton or Miro increases the levels of
active PAR-1
Our results demonstrate that knockdown of milton or Miro
enhances tau-induced neurodegeneration and increases tau
phosphorylation at Ser262. PAR-1 mediates the increase in tau
phosphorylation at Ser262, and tau phosphorylation site Ser262
and PAR-1 are critical for the enhancement of tau-induced
neurodegeneration caused by milton knockdown. To further
investigate the relationship between loss of axonal mitochondria
and PAR-1, the effect of knockdown of milton or Miro on PAR-1
activity was examined.
To detect active PAR-1, a phospho-specific antibody that
recognizes phosphorylated Thr408 of PAR-1, which is important
for PAR-1 activity [37], was used. The titer of the antibody is not
sufficient to detect endogenous PAR-1 in fly eyes [37], but the
antibody recognizes the active form of PAR-1 when PAR-1 is
overexpressed [37]. Co-expression of milton RNAi increases the
Loss of Axonal Mitochondria Promotes Tau Toxicity
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levels of Thr408-phosphorylated PAR-1 in the fly eye (Figure 6A).
In addition to the levels of Thr408-phosphorylated PAR-1, we
observed an increase in total PAR-1 levels with knockdown of
milton (Figure 6A). Similar results were obtained with another
milton RNAi line (milton RNAiTRiP) (Figure 6B). Furthermore,
expression of Miro RNAi also caused an increase in the levels of
Thr408-phosphorylated PAR-1 as well as total PAR-1 in the fly
eyes (Figure 6C). These effects are not due to non-specific effect of
RNAi expression, since the expression of an RNAi against firefly
luciferase did not increase either the levels of Thr408-phosphor-
ylated PAR-1 or total PAR-1 (Figure 6D).
A previous report showed that total PAR-1 level increased when
it was phosphorylated at Thr408 in Drosophila [37]. To examine
whether the increase in PAR-1 levels with milton knockdown is
Thr408-dependent, transgenic flies carrying PAR-1 with unpho-
sphorylatable alanine mutation at Thr408 (PAR-1 T408A) [37]
Figure 2. Milton or Miro knockdown enhances tau-induced axon degeneration. Transmission electron micrographs of lamina areas (A–E)
and presynaptic terminals of photoreceptor neurons in the lamina (F–I) in flies expressing tau (A), flies co-expressing tau and milton RNAi (B, E, F and
G), control flies bearing the gmr-GAL4 driver only (C and H), or flies expressing milton RNAi alone (D and I). Asterisks in A, B, E and F indicate vacuoles.
Arrows in E indicate swollen axons. Arrows in F and G indicate autophagic and multivesicular bodies. All flies were 3 days-after-eclosion (day-old).
doi:10.1371/journal.pgen.1002918.g002
Loss of Axonal Mitochondria Promotes Tau Toxicity
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were used. Milton RNAi coexpression did not increase PAR-1
T408A protein levels (Figure 6E), indicating that Thr408 is
important for the increase in PAR-1 levels caused by milton
knockdown.
Milton knockdown did not cause non-specific activation of
kinases, since it did not increase the level of phosphorylated, active
p44mapk in fly eyes (Figure S11). Moreover, milton knockdown
did not cause non-specific accumulation of overexpressed proteins,
or an increase in the expression of genes under the control of
GAL4/UAS system, since it did not increase the levels of total
p44mapk, GFP, or amyloid precursor protein expressed via the
GAL4/UAS system (Figure S11). Taken together, these results
demonstrate that milton knockdown specifically increases the level
of active PAR-1.
We also observed that the phenotype induced by PAR-1
overexpression was enhanced by milton knockdown. Overexpres-
sion of PAR-1 in fly eyes has been reported to cause eye
degeneration [35], and we found that overexpression of PAR-1
caused age-dependent, mild neurodegeneration in the lamina:
neurodegeneration in the lamina is undetectable in flies overex-
pressing PAR-1 at 3-day-old, while it is detectable at 10-day-old
(Figure S12A–S12C, S12D, quantification). Co-expression of
PAR-1 and milton RNAi caused prominent neurodegeneration
in the lamina at 3-day-old, when neither PAR-1 overexpression
alone or knockdown of milton alone caused neurodegeneration
(Figure S12, S12E–S12G; S12H, quantification). These pheno-
typic analyses further suggest that milton knockdown increases
PAR-1 activity in the eye.
RNAi–mediated knockdown of milton or Miro alone in
neurons causes age-dependent neurodegeneration in
the fly brain
Although knockdown of milton or Miro without human tau
overexpression did not cause neurodegeneration in the young flies
(Figure 1H and 1K), we found that knockdown of milton or Miro
alone caused late-onset neurodegeneration in the fly brain.
Expression of milton RNAi in the fly eyes and brains with a
combination of two GAL4 drivers, the pan-retinal gmr-GAL4
driver and pan-neuronal elav-GAL4 driver, caused age-dependent
neurodegeneration (Figure 7A, 21 days-after-eclosion (day-old)).
Interestingly, although milton RNAi was expressed in the all
neurons in the eye and brain, degeneration was the most
prominent in the optic lobe (Figure 7A). No degeneration was
observed in the brain in flies expressing an RNAi against firefly
luciferase at the same age (Figure 7B, control).
We quantified age-dependent progression of neurodegeneration
caused by milton knockdown in the lamina, where neurodegen-
eration was the most prominent. Degeneration in the lamina is
undetectable at 3-day-old, which is in line with the previous
observation in milton mutant flies [25]. In contrast, degeneration
was observed at 20-day-old and was more prominent at 30-day-
Figure 3. Knockdown of milton or Miro increases tau phosphorylation levels at AD–related Ser262. (A) Milton knockdown increases tau
phosphorylation levels at Ser262. Western blots of eyes from flies expressing tau alone (tau) or co-expressing tau and milton RNAi (tau+milton
RNAiGD). Blots were probed with anti-phospho-Ser262 tau, anti-phospho-Ser202 tau, anti-phospho-Thr231 tau, anti-tau, or anti-tubulin. Tubulin was
used as a loading control. Mean 6 SD, n = 5; *, p,0.05, Student’s t-test. Representative blots are shown. (B) Miro knockdown increases tau
phosphorylation levels at Ser262. Western blots of eyes from flies expressing tau alone (tau) or co-expressing tau and Miro RNAiKK (tau+Miro RNAiKK).
Blots were probed with anti-phospho-Ser262 tau, anti-tau, or anti-tubulin. Tubulin was used as a loading control. Mean 6 SD, n = 5; *, p,0.05,
Student’s t-test. Representative blots are shown. (C) Microtubule binding assay of tau. Proteins were extracted from heads of flies expressing tau
alone (tau) or co-expressing tau and milton RNAi (tau+milton RNAiGD). Tau or tubulin in the lysate before fractionation (total), the fraction free from
microtubules (free) or the fraction containing microtubules (microtubule-bound) were analyzed with western blotting using anti-tau or anti-tubulin.
The same amount of protein was loaded to each lane. Each graph displays tau levels relative to control, or the ratio of free tau relative to microtubule-
bound tau (Mean 6 SD, n = 6; *, p,0.05, Student’s t-test). Representative blots are shown. All flies were 3 days-after-eclosion (day-old).
doi:10.1371/journal.pgen.1002918.g003
Figure 4. PAR-1 mediates the increase in tau phosphorylation at Ser262 caused by milton knockdown. (A) Western blots of eyes from
flies expressing tau alone or co-expressing tau and PAR-1 RNAi. Blots were probed with anti-phospho-Ser262 tau, anti-tau, or anti-tubulin. Mean 6
SD, n = 5; *, p,0.05, Student’s t-test. (B) Western blots of eyes from flies co-expressing tau and PAR-1 RNAi, or co-expressing tau, PAR-1 RNAi and
milton RNAi. Blots were probed with anti-phospho-Ser262, anti-tau, or anti-tubulin. No significant difference was found (mean 6 SD, n = 5; p.0.05,
Student’s t-test). Representative blots are shown. All flies were 3 days-after-eclosion (day-old).
doi:10.1371/journal.pgen.1002918.g004
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old, indicating that milton knockdown causes late-onset and
progressive neurodegeneration (Figure 7, compare 7C (3-day-old),
7D (20-day-old) and 7E (30-day-old); G, quantification of vacuole
areas). No degeneration was observed in the lamina in control flies
at 30-day-old (Figure 7F).
To limit the possibility of off-target effects of RNAi, another
independent transgenic fly line carrying a milton RNAi that
targets a different region of milton (milton RNAiTRiP) was used.
Expression of milton RNAiTRiP also caused age-dependent
neurodegeneration in the lamina (Figure 7H–7J; 7K, quantifica-
tion of vacuole areas). Knockdown of Miro in the fly brains also
caused neurodegeneration in the lamina in aged flies (Figure 7L–
7M; 7N, quantification of vacuole areas). Collectively, these results
suggest that loss of axonal mitochondria is sufficient to cause late-
onset neurodegeneration.
While our paper is under review, it was reported that
knockdown of milton led to progressive axon degeneration in
the Drosophila wing neurons [38].
RNAi–mediated knockdown of Drosophila tau or PAR-1
suppresses milton knockdown-induced
neurodegeneration
The Drosophila tau exhibits a high degree of similarity with the
human tau protein and shares a numbers of important features
such as the microtubule-binding domains [39] and several
phosphorylation sites critical for its functions and toxicity [40].
Overexpression of Drosophila tau has been reported to be capable
of inducing neuronal dysfunction and neurodegeneration [41–43].
We examined whether Drosophila tau is involved in neurodegen-
eration caused by milton knockdown. We found that expression of
RNAi targeting Drosophila tau reduced tau mRNA levels in the fly
brain (Figure S13) and significantly suppressed neurodegeneration
in the lamina caused by milton knockdown (Figure 8A and 8B;
8D, quantification). This effect is not due to titration of the
effectiveness of RNAi, since the expression of an RNAi against
firefly luciferase did not suppress neurodegeneration caused by
milton knockdown (Compare Figure 8A and 8C; 8D, quantifica-
tion). We further examined whether PAR-1 is involved in
neurodegeneration caused by milton knockdown. RNAi-mediated
knockdown of PAR-1 significantly suppressed neurodegeneration
in the lamina of flies expressing milton RNAi (Figure 8E and 8F;
8G, quantification). These results suggest that Drosophila endoge-
nous tau and PAR-1 contribute to milton knockdown-induced
neurodegeneration and further support the conclusions of this
study.
Discussion
Abnormal phosphorylation and toxicity of tau are thought to
play a critical role in the pathogenesis of Alzheimer’s disease (AD).
Accumulation of amyloid-b peptides is thought to be causative for
AD and has been suggested to cause tau abnormality [44–53],
however, the underlying mechanisms are not clear. A reduction in
the number of mitochondria in the axon is observed in the brains
of AD patients [3], and we and others previously reported that
Figure 5. PAR-1 and tau phosphorylation site Ser262 are
critical for the enhancement of tau-induced neurodegenera-
tion caused by milton knockdown. (A–C) PAR-1 knockdown
suppresses the enhancement of tau-induced neurodegeneration
caused by milton knockdown. (A–C) The lamina co-expressing tau
and milton RNAi (A), co-expressing tau, milton RNAi and PAR-1 RNAi (B),
and co-expressing tau, milton RNAi and luciferase RNAi (C). (D)
Quantification of neurodegeneration, mean 6 SEM, n= 12. Significant
difference was found between tau+milton RNAiGD and tau+ milton
RNAiGD+PAR-1 RNAi or between tau+milton RNAiGD +luciferase RNAi
and tau+ milton RNAiGD+PAR-1 RNAi (*, p,0.05, Student’s t-test), but
not between tau+milton RNAiGD and tau+ milton RNAiGD+luciferase
RNAi. All flies were 3 days-after-eclosion (day-old). (E–H) The Ser262
phosphorylation site in tau is necessary for the enhancement of tau-
induced neurodegeneration caused by milton knockdown. (E) Western
blots of the eyes from flies expressing wild-type tau or S262A mutant
tau. Blots were probed with anti-tau or anti-tubulin (loading control).
Expression levels were similar (mean 6 SD, n= 5; p.0.05, Student’s t-
test). (F–H) The lamina co-expressing wild-type tau and milton RNAi (F),
or co-expressing S262A tau and milton RNAi (G). (H) Quantification of
neurodegeneration, presented as mean 6 SEM, n = 9–12. *, p,0.05,
Student’s t-test. All flies were 3 days-after-eclosion (day-old).
doi:10.1371/journal.pgen.1002918.g005
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Figure 6. Knockdown of milton or Miro increases the levels of active PAR-1. (A) Western blots of eyes from flies expressing myc-tagged
PAR-1 alone or flies co-expressing PAR-1 and milton RNAiGD. Blots were probed with anti-phospho-T408 PAR-1 (P-PAR-1), anti-myc (PAR-1), or anti-
tubulin. Tubulin was used as loading control. Mean6 SD, n = 5; *, p,0.05, Student’s t-test. (B) Western blots of eyes from flies expressing myc-tagged
PAR-1 or co-expressing PAR-1 and milton RNAiTRiP. Blots were probed with anti-phospho-T408 PAR-1 (P-PAR-1), anti-myc (PAR-1), or anti-tubulin.
Mean6 SD, n = 5; *, p,0.05, Student’s t-test. (C) Western blots of eyes from flies expressing myc-tagged PAR-1 alone or flies co-expressing PAR-1 and
Miro RNAiKK. Blots were probed with anti-phospho-T408 PAR-1 (P-PAR-1), anti-myc (PAR-1), or anti-tubulin. Mean 6 SD, n = 5; *, p,0.05, Student’s t-
test. (D) Western blots of eyes from flies expressing myc-tagged PAR-1 alone or flies co-expressing PAR-1 and luciferase RNAi. Blots were probed with
anti-phospho-T408 PAR-1 (P-PAR-1), anti-myc (PAR-1), or anti-tubulin. No significant difference was found (mean 6 SD, n = 5; p.0.05, Student’s t-
test). (E) Western blots of eyes from flies expressing myc-tagged PAR-1 T408A alone or flies co-expressing PAR-1 T408A and milton RNAiGD. Blots were
probed with anti-myc (PAR-1 T408A) or anti-tubulin. No significant difference was found (mean 6 SD, n= 5; p.0.05, Student’s t-test). Flies were 3
days-after-eclosion (day-old).
doi:10.1371/journal.pgen.1002918.g006
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amyloid-b peptides reduce the number of mitochondria in the
axons [3–11]. In this study, we examined whether and how loss of
axonal mitochondria increases phosphorylation of human tau at
AD-related sites and enhances tau toxicity. Our data demonstrate
that loss of axonal mitochondria caused by knockdown of milton
or Miro increases tau phosphorylation at an AD-related site
Ser262 through PAR-1, promotes detachment of tau from
microtubules, and enhances tau-mediated neurodegeneration.
These results suggest that loss of axonal mitochondria may play
an important role in tau phosphorylation and toxicity in the
pathogenesis of AD.
It has been reported that, in non-neuronal cultured cells or
primary-cultured hippocampal neurons with virus-mediated over-
expression of human tau, an excess of microtubule-bound tau
blocks microtubule-dependent transport of vesicles and organelle
including mitochondria and causes synaptic degeneration [54,55].
These works have demonstrated that tau phosphorylation at
Ser262 by a PAR-1 homolog MARK2 removes tau from the
microtubule tracks, which restores microtubule-dependent trans-
port of vesicles and organelle, and rescues accompanied synaptic
degeneration [54]. Thus, tau phosphorylation at Ser262 plays a
protective role against tau-induced toxicity in their models in
which an excess of microtubule-bound tau blocks traffic of vesicles
and organelle.
In contrast, this study examined whether and how specific loss
of axonal mitochondria promotes tau phosphorylation and
toxicity. To address this question in vivo, we used a Drosophila
model of human tau toxicity [22]. In this model, we did not
observe severe defects in microtubule-dependent transport under
our experimental condition, since mitochondria are present at the
synaptic terminals of neurons expressing human tau in the young
flies (Figure S2). To chronically deplete mitochondria from the
axon, we used knockdown of milton or Miro. The most critical
difference between the models used in Thies and Mandelkow [54]
and our model is that, in the models of Thies and Mandelkow,
mitochondrial transport defects were depending on tau binding to
microtubules, while in our model, mitochondria were chronically
depleted from the axon by milton knockdown.
Using this model system, we found that milton knockdown
significantly enhanced tau-mediated neurodegeneration. Milton
knockdown increased the levels of active PAR-1 and tau
phosphorylation at Ser262, and promoted detachment of tau
from microtubules. If the enhancement of tau toxicity caused by
milton knockdown in our model is due to an additive reduction in
the number of axonal mitochondria, blocking tau phosphorylation
at Ser262, which increases tau binding to microtubules and blocks
microtubule-dependent transport, would enhance neurodegener-
ation. However, our results have shown that blocking tau
phosphorylation at Ser262 by PAR-1 knockdown rescues the
enhancement of tau-mediated neurodegeneration in the milton
knockdown background. These results suggest that the enhance-
ment of tau toxicity in the milton knockdown background is not
likely to be due to an additive reduction of axonal transport of
mitochondria caused by an excess of microtubule-bound tau.
Rather, this study suggests that, when axonal mitochondria are
Figure 7. RNAi–mediated knockdown of milton or Miro in
neurons causes age-dependent neurodegeneration in the fly
brain. (A–B) The brain of flies expressing milton RNAi with a
combination of two drivers, the pan-neuronal elav-GAL4 driver and
pan-retinal gmr-GAL4 driver (A) and control (luciferase RNAi) (B). Flies
are at 21-day-old. Neurodegeneration is indicated by arrows. (C–G) The
lamina in flies expressing milton RNAi at 3-day-old (C), 20-day-old (D) or
30-day-old (E), or the lamina of control flies (gmr-GAL4 driver only) at
30-day-old (F). (G) Quantification of neurodegeneration (indicated by
arrows in D and E), mean 6 SEM, n = 10–12. *, p,0.05, Student’s t-test.
(H-K) Quantification of neurodegeneration in the lamina in the flies
expressing milton RNAiTRiP with a combination of the elav-GAL4 driver
and gmr-GAL4 driver at 10-day-old (H) and 20-day-old (I), or
neurodegeneration in the lamina of control flies (drivers only) at 30-
day-old (J). (K) Quantification of neurodegeneration (arrows in H and I).
Mean6 SEM, n = 10–12. *, p,0.05, Student’s t-test. (L–N) Quantification
of neurodegeneration in the lamina in the flies expressing Miro RNAiKK
with the gmr-GAL4 driver (L) or in the lamina of control flies (drivers
only) (M) at 40-day-old. (N) Quantification of neurodegeneration (arrows
in L). Mean 6 SEM, n = 10–12. *, p,0.05, Student’s t-test.
doi:10.1371/journal.pgen.1002918.g007
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chronically depleted, increased free, microtubule-unbound,
Ser262-phosphorylated tau promotes neurodegeneration.
A fine-tuned balance of microtubule-binding of tau is critical for
its physiological functions. It has been suggested that both an
excess of microtubule-bound tau and an excess of free, microtu-
bule-unbound tau can cause toxicity [56]. Since tau phosphory-
lation at Ser262 promotes tau detachment from microtubules
[32,33], Ser262 phosphorylation by MARK/PAR-1 plays critical
roles under both physiological and pathological conditions. Thus,
when axonal distribution of vesicles and organelle are reduced by
tau, detachment of tau can play a protective role by temporarily
enhancing microtubule-dependent transport [54]. However, our
results suggest that, under pathological environments in which
axonal mitochondria are chronically depleted, microtubule-
unbound, free, Ser262-phosphorylated tau in the axons may
become toxic and cause neurodegeneration.
We found that the levels of active PAR-1 are increased by milton
knockdown (Figure 6). PAR-1 is activated by various stress stimuli
such as high osmolarity and amyloid precursor protein accumula-
tion in Drosophila [37]. Our results suggest that loss of axonal
mitochondria may trigger a process that increases the levels of active
PAR-1. However, the detailed mechanisms by which milton
knockdown increases the levels of active PAR-1 require further
investigations. PAR-1 activity is regulated by various kinases
including LKB1, aPKC, and Death-associated protein kinase
(DAPK) [37,57,58]. A recent report demonstrated that PAR-1
protein levels were regulated by theDrosophila homolog of adducin, a
cytoskeletal protein involved in regulating actin filament dynamics
[59]. Milton knockdown may act through one or a combination of
the mechanisms to increase the level of active PAR-1.
Detachment of tau from microtubules has been suggested to
initiate its abnormal metabolism and toxicity of tau in AD
pathogenesis [56], however, the underlying mechanisms are not
fully understood. This study shows that loss of axonal mitochon-
dria promotes detachment tau from microtubules and enhances
tau-mediated neurodegeneration, and tau phosphorylation at AD-
related Ser262 by PAR-1 plays a critical role in this process. Our
results also suggest that an increase in Ser262-phosphorylated,
microtubule-unbound tau may contribute to neurodegeneration
under pathological conditions in which axonal mitochondria is
depleted. An important question is how free, microtubule-
unbound, Ser262-phosphorylated tau causes neurodegeneration
under such pathological conditions. Loss of axonal mitochondria
would disrupt multiple signaling pathways in the axon, and those
changes may further enhance toxicity of tau. Elucidation of such
mechanisms will further our understanding of tau-mediated
neurodegeneration in the pathogenesis of AD.
In summary, this study highlights a potential role of loss of
axonal mitochondria in tau phosphorylation and toxicity in AD
pathogenesis. Reductions in the function and number of
mitochondria in the axon have also been implicated in several
neurodegenerative diseases such as Parkinson’s disease, Hunting-
ton’s disease, and amyotrophic lateral sclerosis [60]. Our study
raises an interesting possibility that mitochondrial mislocalization




Transgenic fly lines carrying UAS-luciferase RNAi were
established following the method described previously [61]. Target
sequences were amplified by PCR from luciferase cDNA using
primers (for, 59-CCGGAATTCGATATGGGCTGAATA-
CAAATCACAGAATCG-39, rev, 59-CTAGTCTAGATTCAT-
TAAAACCGGGAGGTAGATGAGATGT-39 ), and the result-
ing constructs were subcloned into the pUAST Drosophila
transformation vector and microinjected into fly embryos of the
w1118 genotype. Transgenic fly lines carrying UAS-Miro RNAi
were established by microinjecting the Miro RNAi construct (a
Figure 8. RNAi–mediated knockdown of Drosophila tau or PAR-
1 suppresses milton knockdown-induced neurodegeneration.
(A–D) The lamina of flies expressing milton RNAi alone (A), co-
expressing milton RNAi and Drosophila tau RNAi (B), and co-expressing
milton RNAi and luciferase RNAi (C). (D) Quantification of neurodegen-
eration (indicated by arrows), mean 6 SEM, n = 12. *, p,0.05, Student’s
t-test. Flies were 30-day-old. (E–G) The lamina of flies expressing milton
RNAi alone (E) and co-expressing milton RNAi and PAR-1 RNAi (F). (G)
Quantification of neurodegeneration (indicated by arrows), mean 6
SEM, n = 10–12. *, p,0.05, Student’s t-test. Flies were 30-day-old.
doi:10.1371/journal.pgen.1002918.g008
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kind gift from Dr. Barry Dickson (Research Institute of Molecular
Pathology, Austria)) into fly embryos of the w1118 genotype. The
transgenic fly lines carrying S262A mutant tau was described
previously [36]. Other fly stocks are listed in Table S1. Fly
genotypes used in each experiment are listed in Table S2.
Electron microscopy
Probosces were removed from decapitated heads, which were
then immersion-fixed overnight in 2.5% glutaraldehyde and 2%
paraformaldehyde in 0.1 M sodium cacodylate buffer at 4uC.
Samples were post-fixed 1 hr in 1% osmium tetroxide in 0.1 M
sodium cacodylate buffer on ice. After washing, samples were
stained en bloc with 0.5% aqueous uranyl acetate for 1 hr,
dehydrated with ethanol and embedded in Epon. Thin-sections
(70 nm) of laminas, in which photoreceptor axons were cut
longitudinally, were collected on copper grids. The sections were
stained with 2% uranyl acetate in 70% ethanol and Reynolds’ lead
citrate solution. Electron micrographs were obtained with a
VELETA CCD Camera (Olympus Soft Imaging Solutions
GMBH) mounted on a JEM-1010 electron microscope (Jeol Ltd.).
Histological analysis
Preparation of paraffin sections, hematoxylin and eosin staining,
and analysis of neurodegeneration were described previously [53].
To analyze internal eye structure, heads of female flies were fixed
in Bouin’s fixative (EMS) for 48 hr at room temperature,
incubated 24 hr in 50 mM Tris/150 mM NaCl, and embedded
in paraffin. Serial sections (6 mm thickness) through the entire
heads were prepared, stained with hematoxylin and eosin (Vector),
and examined by bright-field microscopy. Images of the sections
that include the lamina were captured with Insight 2 CCD
Camera (SPOT), and vacuole area was measured using Image J
(NIH). Heads from more than five flies (more than 10
hemispheres) were analyzed for each genotype.
Western blotting
Twenty fly heads for each genotype were homogenized in SDS-
Tris-Glycine sample buffer, and the same amount of the lysate was
loaded to each lane of multiple 10% Tris-Glycine gels and
transferred to nitrocellulose membrane. The membranes were
blocked with 5% milk (Nestle), blotted with the antibodies
described below, incubated with appropriate secondary antibody
and developed using ECL plus Western Blotting Detection
Reagents (GE Healthcare) or imaging with an Odyssey system.
One of the membranes was probed with anti-tubulin, and used as
the loading control for other blots in each experiment. Anti-tau
monoclonal antibody (Tau46, Zymed), and anti-tau pSer262
(Biosource and Calbiochem), phospho-Thr231 (AT180, Thermo
and Endogen), anti-HA (Santa Cruz), anti-myc (Millipore), anti-
active p44mapk (Promega), anti-tubulin (Sigma), anti-GFP (Clon-
tech) were purchased. Anti-tau pS202 (CP13) was a kind gift from
Dr. Peter Davis (Albert Einstein College of Medicine). Anti-PAR-1
pT408 was described previously [37]. The signal intensity was
quantified using ImageJ (NIH) or an Odyssey system. Western
blots were repeated a minimum of three times with different
animals and representative blots are shown. Flies used for Western
blotting were 3–5 day-old after eclosion.
RNA extraction and quantitative real-time PCR analysis
Quantitative real-time PCR analysis was performed as de-
scribed previously [53]. More than thirty flies for each genotype
were collected and frozen. Heads were mechanically isolated, and
total RNA was extracted using TRIzol (Invitrogen) according to
the manufacturer’s protocol with an additional centrifugation step
(11,0006g for 10 min) to remove cuticle membranes prior to the
addition of chloroform. Total RNA was reverse-transcribed using
Superscript II reverse transcriptase (Invitrogen), and the resulting
cDNA was used as a template for PCR on a 7500 fast real time
PCR system (Applied Biosystems). The average threshold cycle
value (Ct) was calculated from five replicates per sample.
Expression of genes of interest was standardized relative to actin,
rp49 or TBP. Relative expression values were determined by the
deltaCt method according to quantitative PCR Analysis User











rp49 rev 59- GTTCGATCCGTAACCGATGT-39
TBP for 59- GCGGCTGTGATTATGCGAAT-39
TBP rev 59-AGGGAAACCGAGCTTTTGGA-39
Microtubule binding assay
Microtubule binding assay was performed using a previously
reported procedure with a modification [62]. Fifty heads from
adult flies expressing the human tau protein with the gmr-GAL4
driver were collected and homogenized in 150 ml of Buffer-C+
[50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
pH 7.1, 1 mM MgCl2, 1 mM ethylene glycol tetraacetic acid,
protease inhibitor cocktail (Roche), and phosphatase inhibitor
cocktail (Sigma-Aldrich)] in the presence of taxol 20 mM (Sigma-
Aldrich) diluted in dimethylsulfoxide. After centrifugation at
1,0006 g for 10 min, aliquot of supernatant was subjected to
Western blotting as the ‘‘total fraction’’. The remaining superna-
tant was layered onto a 2 volume cushion of buffer-C+ with 50%
sucrose. After centrifugation at 100, 0006g for 30 min, the upper
fraction containing soluble tubulin was collected as the microtu-
bule-free fraction and the pellet containing microtubule polymers
and proteins bound to microtubules was resuspended in 150 ml of
SDS-Tris-Glycine sample buffer. Protein concentration in each
fraction was measured using the BCA Protein Assay Kit (Pierce).
The same amount of protein was loaded to each lane of Tris-
Glycine gels and analyzed by western blotting using anti-tau
antibody (Tau46, Zymed) or anti-tubulin (Sigma). For quantifica-
tion, the signal intensity in each lane was quantified with an
Odyssey system.
Statistics
Statistics was done with the JMP software (SAS) with Student’s t
or Tukey-Kramer HSD. Values are given as mean 6 standard
deviation or standard error.
Supporting Information
Figure S1 Expression of human 0N4R wild-type tau causes late-
onset, progressive neurodegeneration in the lamina. The lamina
expressing tau at 3-day-old (A) or 10-day-old (B), or the lamina of
control flies (gmr-GAL4 driver only) at 10-day-old (C). Compare
vacuoles indicated by arrows in A (3-day-old) and B (10-day-old).
(D) Quantification of the area of vacuoles in the lamina (arrows in
A and B), mean 6 SEM, n= 14–20. *, p,0.05, Student’s t-test.
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Genotypes are as follows: (tau) +/+;gmr-GAL4/+;UAS-tau/+ and
(control) +/+;gmr-GAL4/+;+/+.
(TIF)
Figure S2 Mitochondria are observed in the presynaptic
terminals of photoreceptor neurons expressing tau. Transmission
electron micrographs of presynaptic terminals in the lamina of flies
expressing human tau. Presynaptic terminals are colored green to
accentuate the structures. Arrows indicate mitochondria in
synaptic terminals. Flies were 3 days-after-eclosion (day-old).
Genotype is: +/+;gmr-GAL4/+;UAS-tau/+.
(TIF)
Figure S3 Presynaptic terminals in milton knockdown flies have
larger vesicles. Transmission electron micrographs of presynaptic
terminals in the lamina of control flies bearing the gmr-GAL4
driver only (control) and flies with milton knockdown (milton
RNAiGD). Flies were 3 days-after-eclosion (day-old). Genotypes are
as follows: (control) +/+;gmr-GAL4/+;+/+ and (milton RNAiGD)
UAS-milton RNAiGD/+;gmr-GAL4/+;+/+.
(TIF)
Figure S4 Milton knockdown causes loss of axonal mitochondria
in the photoreceptor neurons expressing human tau in the fly
brain. A representative transmission electron micrograph of a
presynaptic terminal of a photoreceptor neuron in the lamina of
the fly co-expressing human tau and milton RNAi. The
presynaptic terminal is colored green to accentuate the structures.
Note that mitochondria are not observed (compare to Figure S2).
Flies were 3 days-after-eclosion (day-old). Genotype is: UAS-
milton RNAiGD/+;gmr-GAL4/+;UAS-tau/+.
(TIF)
Figure S5 Milton RNAiTRiP reduces milton mRNA levels and
causes mislocalization of mitochondria in the fly brain. (A)
Reduction in milton mRNA levels by the expression of milton
RNAiTRiP in eyes and neurons. Expression of UAS-luciferase
(control) or UAS-milton RNAiTRiP (milton RNAiTRiP) was driven
by a combination of two drivers, the pan-retinal gmr-GAL4 driver
and pan-neuronal elav-GAL4 driver. More than thirty flies for
each genotype were collected and frozen. Heads were mechan-
ically isolated, and total RNA was extracted. Milton RNA levels
were quantified by qRT-PCR (presented as mean 6 SD, n= 5,
*p,0.05, Student’s t-test). Note that milton RNAi is only
expressed in eyes and neurons, while endogenous milton is
ubiquitously expressed. Genotypes are as follows: (control) elav-
GAL4/Y;gmr-GAL4/+;UAS-luciferase/+ and (milton RNAiTRiP)
elav-GAL4/Y;gmr-GAL4/+;UAS-milton RNAiTRiP/+. (B) Milton
RNAiTRiP reduces axonal mitochondrial in the fly brain. (Top) A
schematic view of the mushroom body structure, where axons
(orange) can be easily identified in the fly brain. (Bottom) Mito-
GFP signal in the lobe tips. Ratios relative to control are shown
(mean 6 SD, n= 6; *, p,0.05, Student’s t-test). The mito-GFP
signal in the axons was significantly decreased in the milton
RNAiTRiP fly brains. Representative images are shown. The
method for mito-GFP analysis in the brain is described in Text S1.
Genotypes are as follows: (control) elav-GAL4/Y;mito-GFP/+;+/
+ and (milton RNAiTRiP) elav-GAL4/Y;mito-GFP/+; milton
RNAiTRiP/+.
(TIF)
Figure S6 Miro RNAiKK reduces axonal mitochondria in the fly
brain. Mito-GFP signal in the lobe tips (axons) of the mushroom
body structure in the brains of control and Miro RNAiKK flies.
Representative images are shown at the top, and the ratio of mito-
GFP signal in the lobe tips relative to control are shown at the
bottom (mean6 SD, n= 6; *, p,0.05, Student’s t-test). Genotypes
are as follows: (control) elav-GAL4/Y;mito-GFP/+;+/+ and (Miro
RNAiKK) elav-GAL4/Y;mito-GFP/UAS- Miro RNAiKK;+/+.
(TIF)
Figure S7 Miro RNAiiai causes a reduction in Miro mRNA
levels in the fly brain. Expression of UAS-Miro RNAiiai (Miro
RNAiiai) was driven by the pan-neuronal elav-GAL4 driver.
More than thirty flies for control flies (the elav-GAL4 driver only)
or Miro RNAi flies were collected and frozen. Heads were
mechanically isolated, and total RNA was extracted. Miro
mRNA levels were quantified by qRT-PCR (presented as mean
6 SD, n= 5, *, p,0. 05, Student’s t-test). Note that Miro RNAiiai
is only expressed in neurons, while endogenous Miro is
ubiquitously expressed. Genotypes are as follows: (control) elav-
GAL4/Y;+/+;+/+ and (Miro RNAi) elav-GAL4/Y;+/+;UAS-
Miro RNAiiai/+.
(TIF)
Figure S8 Tau-mediated neurodegeneration in the lamina is not
enhanced by RNAi targeting CG30106, CG4395, CG6064, or
CG30340. Quantification of neurodegeneration measured by the
area of vacuoles in the lamina, presented as mean6 SEM, n= 10–
12. The asterisk indicates significant difference between tau and
tau+milton RNAi (p,0.05, Student’s t-test). Flies were 3 days-
after-eclosion (day-old).
(TIF)
Figure S9 Knockdown of milton or Miro does not enhance tau-
mediated reduction in the external eye size. Eyes from flies
carrying the pan-retinal gmr-GAL4 driver only (control) (A),
expressing human tau alone (tau) (B), co-expressing human tau
and milton RNAi (tau+milton RNAiGD) (C), co-expressing human
tau and Miro RNAiiai (tau+Miro RNAi) (D), or expressing milton
RNAi alone (milton RNAiGD) (E). Genotypes are as follows:
(control) +/+;gmr-GAL4/+;+/+, (tau) +/+;gmr-GAL4/+;UAS-
tau/+, (tau+milton RNAiGD) UAS-milton RNAiGD/+;gmr-
GAL4/+;UAS-tau/+, (tau+Miro RNAi) +/+;gmr-GAL4/+;UAS-
tau/UAS-Miro RNAiiai and (milton RNAiGD) UAS-Milton
RNAiGD/+;gmr-GAL4/+;+/+.
(TIF)
Figure S10 Expression of S262A tau causes late-onset, progres-
sive neurodegeneration in the lamina. The lamina expressing
S262A tau at 3-day-old (A) or 10-day-old (B). Vacuoles in A are
indicated by arrows. (C) Quantification of the area of vacuoles in
the lamina, mean 6 SEM, n= 10–12. *, p,0.05, Student’s t-test.
Genotype is: +/+;gmr-GAL4/+;UAS-S262Atau/+.
(TIF)
Figure S11 Milton knockdown does not cause non-specific
activation of kinases, non-specific accumulation of overexpressed
proteins, or an increase in the expression of proteins under the
control of GAL4/UAS system. (A) Western blots of eyes from flies
expressing HA-tagged p44mapk alone or flies co-expressing
p44mapk and milton RNAiGD. Blots were probed with anti-
phospho-mapk (P-p44mapk) or anti-tubulin. No significant
differences were found (mean 6 SD, n= 5; p.0.05, Student’s t-
test). The asterisk indicates non-specific bands. (B) Western blots of
eyes from flies expressing HA-tagged p44mapk alone or flies co-
expressing p44mapk and milton RNAiGD. Blots were probed with
anti-HA (p44mapk) or anti-tubulin. No significant differences were
found (mean 6 SD, n= 5; p.0.05, Student’s t-test). (C) Western
blots of eyes from flies expressing GFP alone or flies co-expressing
GFP and milton RNAiGD. Blots were probed with anti-GFP or
anti-tubulin. No significant differences were found (mean 6 SD,
n= 5; p.0.05, Student’s t-test). (D) Western blots of eyes from flies
expressing myc-tagged APP alone or flies co-expressing APP and
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milton RNAiGD. Blots were probed with anti-myc (APP) or anti-
tubulin. No significant differences were found (mean 6 SD, n= 5;
p.0.05, Student’s t-test). All flies were 3 days-after-eclosion (day-
old). Genotypes are as follows: (p44mapk) +/+;gmr-GAL4/
+;UAS-p44mapk-HA/+, (p44mapk+milton RNAi) UAS-Milton
RNAiGD/+;gmr-GAL4/+;UAS-p44mapk-HA/+, (GFP) +/+;gmr-
GAL4/UAS-GFP;+/+, (GFP+milton RNAi) UAS-Milton
RNAiGD/+;gmr-GAL4/UAS-GFP;+/+, (APP) +/+;gmr-GAL4/
UAS-APP-myc;+/+ and (APP+milton RNAi) UAS-Milton
RNAiGD/+;gmr-GAL4/UAS-APP-myc;+/+.
(TIF)
Figure S12 Milton knockdown enhances neurodegeneration
caused by PAR-1 overexpression. (A–D) PAR-1 overexpression
causes late-onset, progressive neurodegeneration in the lamina.
The lamina expressing PAR-1 at 3 days-after-eclosion (day-old) (A)
or 10-day-old (B), or the lamina of control flies at 10-day-old (C).
(D) Quantification of the area of vacuoles in the lamina (arrows in
B), mean 6 SEM, n= 10–12. *, p,0.05, Student’s t-test. (E–H)
Milton knockdown enhances PAR-1-induced lamina degenera-
tion. The lamina of flies expressing PAR-1 alone (E), co-expressing
PAR-1 and milton RNAiGD (F), and expressing milton RNAiGD
alone (G) are shown. (H) Quantification of neurodegeneration
(arrows in F), mean 6 SEM, n= 10–12. *, significant difference
between PAR-1 and PAR-1+milton RNAiGD (p,0.05, Student’s
t-test). Genotypes are as follows: (control) +/+;gmr-GAL4/+;+/+,
(PAR-1) +/+;gmr-GAL4/+;UAS-PAR-1-myc/+, (PAR-1+milton
RNAiGD) UAS-Milton RNAiGD/+;gmr-GAL4/+;UAS-PAR-1-
myc/+ and (milton RNAiGD) UAS-Milton RNAiGD/+;gmr-
GAL4/+;+/+.
(TIF)
Figure S13 Tau RNAi causes a reduction in tau mRNA levels in
the fly brain. Expression of UAS-luciferase (control) or UAS-tau
RNAi (tau RNAi) was driven by a combination of two drivers, the
pan-retinal gmr-GAL4 driver and pan-neuronal elav-GAL4
driver. More than thirty flies for each genotype were collected
and frozen. Heads were mechanically isolated, and total RNA was
extracted. Tau mRNA levels were quantified by qRT-PCR
(presented as mean 6 SD, n= 5, *, p,0.05, Student’s t-test).
Genotypes are as follows: (control) elav-GAL4/Y;gmr-GAL4/
+;UAS-luciferase/+, and (tau RNAi) elav-GAL4/Y;gmr-GAL4/
+;UAS-tau RNAi/+.
(TIF)
Table S1 Fly stocks.
(DOC)
Table S2 Genotypes of the flies that were used in each
experiment.
(DOC)
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